Compare LCII & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCII | OGN |
|---|---|---|
| Founded | 1956 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | N/A | N/A |
| Metric | LCII | OGN |
|---|---|---|
| Price | $121.37 | $6.99 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $102.40 | $14.10 |
| AVG Volume (30 Days) | 277.5K | ★ 4.9M |
| Earning Date | 10-30-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.78% | 1.12% |
| EPS Growth | ★ 38.80 | N/A |
| EPS | ★ 7.12 | 1.91 |
| Revenue | $3,992,455,000.00 | ★ $6,301,000,000.00 |
| Revenue This Year | $10.55 | N/A |
| Revenue Next Year | $4.21 | N/A |
| P/E Ratio | $17.10 | ★ $3.75 |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $72.31 | $6.18 |
| 52 Week High | $123.00 | $17.23 |
| Indicator | LCII | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 70.08 | 40.70 |
| Support Level | $120.15 | $6.90 |
| Resistance Level | $123.00 | $7.49 |
| Average True Range (ATR) | 2.87 | 0.28 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 82.39 | 12.56 |
LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.